Some GIST patients lack KIT and PDGFRA mutations, and approximately 20%–40% of GISTs deficient in KIT and PDGFRA mutations show succinate dehydrogenase (SDH) complex defects, and the therapeutic role of TKIs in patients with SDH-deficient GIST remains controversial. Here, KIT is linked to gastrointestinal stromal tumor.